6 results
Recurrent / Breakthrough DVT During Anticoagulation

Subtherapeutic Anticoagulation
Hypercoagulable State 
 - Antithrombin deficiency 
 - Hypercoagulability ot
/ Breakthrough DVT ... APLS - MPN/PNH ... Structural - Pelvic masses ... #VTE #anticoagulation ... #hematology #differential
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
DVT = deep vein ... thrombosis; PE = pulmonary ... body mass index; VTE ... Anticoagulation #Management ... #Hematology #Oncology
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
Causes of Breakthrough ... Thrombosis and Management ... Algorithm #Extension #VTE ... #DVT #Hematology ... #Differential #Causes
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
algorithm for VTE ... and incidental DVT ... without concomitant DVT ... Anticoagulation #Management ... #Hematology #Oncology
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
myalgias, HoTN, edema ... Imaging: CXR- pulmonary ... APML #diagnosis #management ... #hematology #oncology
Anti-NXP-2 Dermatomyositis

What?
DM with generalized subcutaneous edema
Pts have more myalgias, more severe weakness, and an increased prevalence
Pts have more ... Muscle atrophy may cause ... three days #AntiNXP2DM ... #diagnosis #management ... #rheumatology #